Intellectual Property Services
The valuation of pharmaceutical, medical device, and biologic intellectual property for a variety of purposes including capital projects, mergers and acquisitions, litigation support, investments, tax matters, and financial reporting is often relied upon by healthcare and life sciences industry entities and practices.
Frier Levitt offers a full line of Intellectual Property (IP) legal services to protect your business and inventions.
Our team can assist with:
- Patent, Trademark and Copyright registrability opinions, preparation and prosecution before the U.S. Patent & Trademark Office
- Patent Infringement and Intellectual Property disputes and litigation
- Copyright and Trademark filings
- Prosecution and Advocacy before the Trademark Trial and Appeal Board
- Trade Secrets
- Patent Invalidity and Freedom-to-Operate Opinions
- Strategic Due Diligence
- Patent Portfolio Management and Valuation
- Hatch Waxman matters and ANDA certifications
Building and Valuing IP Portfolio
Leveraging our resources, we offer our clients services ranging from patent and trademark searches, to preparation and prosecution of patent applications before the U.S. Patent & Trademark Office, to patent enforcement services to protect against possible infringement once your patent has been approved.
Valuation of intellectual property rights is part of the good management of IP within an organization. Indeed, knowing the economic value and importance of the IP rights you create and develop assists in the strategic decisions to be taken on the assets, and facilitates the commercialization and transactions concerning intellectual property rights.
There are many business situations where valuation is required:
- Valuation of a company for the purposes of a merger, acquisition, joint venture or bankruptcy.
- Negotiations to sell or license intellectual property rights.
- Support in situations of conflict, such as court proceedings or alternative dispute resolution mechanisms (such as arbitration).
- Fund raising through bank loans or venture capital.
The fourth type of intellectual property, in addition to patents, trademarks, and copyrights, is trade secrets. Most states have adopted portions of the Uniform Trade Secrets Act. A trade secret owner can collect damages for any economic injury suffered as a result of improper acquisition and use of a trade secret. Frier Levitt attorneys routinely protect, maintain and enforce their clients’ trade secret rights and defend them against misappropriation. We advise clients on best practices for trade secret protection and conduct pre-litigation investigations.
Our Team Can Help With Your Intellectual Property Needs
Our team includes seasoned Intellectual Property attorneys. We deploy IP knowledge to create smart value for clients. We work with our clients to develop, manage and defend their IP portfolios.
Frier Levitt offers a full range of Intellectual Property (IP) Services for pharmaceutical, medical device, consumer products, and business methods. Our IP team has over 20 years of experience handling all aspects of patent law with in-depth knowledge of the complexities and nuances of patents.
We know the value that IP can provide and our patent, trademark and copyright services are customized to meet the individual needs of our clients. CONTACT US today to learn how we can help leverage your IP needs.
Related Resource Publications
Rumore MM. Intellectual Property in the Drug Discovery Process. O’Donnell JT. Drug Discovery and Development. 3nd ed. Taylor & Francis, 2019. Chapter 22.
Wong A YT, Rumore MM, Chan AK. Biosimilars in the United States: Emerging Issues in Litigation. BioDrugs. 2017 (April); DOI 10.1007/s40259-017-0216-7.
Rumore M, Safe Harbor or Pirate Cove? Merck v. Integra and Its Seeming Impact on International Research Activities. SciTech Lawyer 3(3):12-15, Winter 2007.
Restino L, Rumore MM. Safe Harbor or Uncharted Seas? Integra v. Merck Currents. N.J. Lawyer 14(20):1,6, 2005.
Vepachedu S, Rumore M. Patent Protection and the Pharmaceutical Industry in the Indian Union. Intellectual Property Today 11:44-46, Oct. 2004.
Rumore M. Determinants of Patenting in the U.S. Pharmaceutical Industry Based on Recent CAFC Case Law. J. Amer. Pharm. Assoc. 44:298, Mar/April 2004.
Rumore M. Ranbaxy Pharmaceuticals v. Apotex. Redefining Claim Drafting and Patent Prosecution Under Festo. ABA Intellectual Property Newsletter. 22:12-15, Summer 2004.